Tolga CANBAK, Huseyin Kerem TOLAN

Neuroendocrine tumors of the appendix

Aim: The objective of this study was to evaluate treatment and postoperative recurrence in patients with neuroendocrine tumors ofthe appendix detected.Material and Methods: Patients with neuroendocrine tumors of the appendix detected between January 2015 and January 2016were evaluated retrospectively. Patients who underwent incidental appendectomy due to different malignancies were excluded fromthe study.Results: A total of 402 patients who underwent appendectomy were evaluated. Five patients with neuroendocrine tumors detected,were included in the study. The mean age was 30.1 years. There were tumors in the apex, while a second tumor was found in the corpusin one patient. The mean tumor diameter was 0.6 cm. Ki-67 was under 2% in all patients. One patient underwent right hemicolectomyin the postoperative first month due to the infiltration to the periappendiceal tissue. The mean duration of hospitalization was 2 days.The mean duration of follow-up was 38 months (range 12- 54) . Ga 68 PET CT was taken in all patients after the histopathologicalexamination. Control of the patients was performed after the first year with thorax and abdominal CT. None of the patients developedtumor.Conclusion: In general, clinical course is good and appendectomy is curative. However, right hemicolectomy is needed in patientswith poor prognostic factors.

PDF

___

1. Tchana-Sato V, Detry O, Polus M, et al. Carcinoid tumor of the appendix: a consecutive series from 1237 appendectomies. World J Gastroenterol 2006;12:6699-701.
2. Gu Y, Wang N, Xu H. Carcinoid tumor of the appendix: a case report. Oncol Lett 2015;9:2401–3.
3. Murray SE, Lloyd RV, Sippel RS, et al. Postoperative surveillance of small appendiceal carcinoid tumors. Am. J. Surg 2014;207:342–5.
4. Spallitta SI, Termine G, Stella M, et al. Carcinoid of the appendix. A case report. Minerva Chir. 2000;55:77–87.
5. Barretoa SG, Tionga L, Thomasa T, et al. Incidental appendiceal carcinoids: is surgery affecting their incidence? World J Oncol 2012;3:227–30.
6. Tchana-Sato V, Detry O, Polus M, et al. Carcinoid tumor of the appendix: a consecutive series from 1237 appendectomies. World J. Gastroenterol 2006;12:6699–701.
7. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 2008;26:3063–72.
8. Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008;113:2655–64.
9. Amr B, Froghi F, Edmond M, et al. Management and outcomes of appendicular neuroendocrine tumours: retrospective review with 5-year follow-up. Eur J Surg Oncol 2015;41:1243–6.
10. Anwar K, Desai M, Al-Bloushi N, et al. Prevalence and clinicopathological characteristics of appendiceal carcinoids in Sharjah (United Arab Emirates) World J Gastrointest Oncol 2014;6:253–6.
11. Goede AC, Caplin ME, Winslet MC. Carcinoid tumour of the appendix. Br J Surg 2003;90:317-22.
12. Fornaro R, Frascio M, Sticchi C, et al. Appendectomy or right hemicolectomy in the treatment of appendiceal carcinoid tumors? Tumori 2007;93:587-90.
13. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59.
14. Tchana-Sato V, Detry O, Polus M, et al. Carcinoid tumor of the appendix: a consecutive series from 1237 appendectomies. World J Gastroenterol 2006;12:6699-701.
15. Sweeney JF, Rosemurgy AS. Carcinoid tumors of the gut. Cancer Control 1997;4:18-24.